A research team led by Dr. Jane R. Montealegre of the University of Texas MD Anderson Cancer Center aimed to assess whether at-home collection of samples using mailed self-collection kits could ...

As their first-line treatment, people with HR-positive, HER2-negative advanced breast cancer often receive hormone therapy—most commonly an aromatase inhibitor—given in combination with a CDK4/6 ...

The global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. One in 5 men and one in 6 women worldwide develop cancer during their lifetime, and one in ...

Meanwhile, across the country, members of the Los Angeles Pink Dragons, trained in the summer for the annual International Dragon Boat festival in Long Beach, California, held in July, and the 10 th ...

In December, the same research group published another study showing a survival benefit for small-cell lung cancer patients who received checkpoint inhibitors before mid-afternoon. A morning advantage ...

Published in JAMA Open Network, the new research showed minimal improvement in racial disparities. In fact, data from 2005 to 2019 showed that Black patients were 13% to 15% less likely to receive ...

During chemotherapy, 29% of participants in the cooling group developed at least Grade 2 neuropathy in the frozen-glove hand, compared with 50% in the untreated hand. In the compression group, 24% had ...

Galleri, a blood test that aims to detect over 50 cancers, illustrates the promise and popularity of an emerging technology to screen for cancer. Although the blood test is not approved by the Food ...

A combination, triplet therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in nearly all patients with recurrent or persistent estrogen receptor- (ER-) ...

“These updated recommendations will help to improve compliance with screening and reduce the risk of cervical cancer,” said Dr. Robert Smith, senior vice president, early cancer detection science at ...

Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body ...

Akiko Hanai of Kyoto University and her colleagues studied peripheral neuropathy prevention in 40 women receiving paclitaxel for breast cancer. The average age was 56. The women wore Elasto-Gel frozen ...